Contact
Please use this form to send email to PR contact of this press release:
Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
TO:
Please use this form to send email to PR contact of this press release:
Algernon Receives Clearance from Health Canada for Ifenprodil COVID-19 Phase 2b/3 Multinational Clinical Trial
TO: